On Monday, CERo Therapeutics Holdings Inc (NASDAQ: CERO) opened lower -23.60%% from the last session, before settling in for the closing price of $10.68. Price fluctuations for CERO have ranged from $6.71 to $895.40 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 51.33% at the time writing. With a float of $0.36 million, this company’s outstanding shares have now reached $0.52 million.
In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
CERo Therapeutics Holdings Inc (CERO) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of CERo Therapeutics Holdings Inc is 29.58%, while institutional ownership is 6.79%. The most recent insider transaction that took place on Dec 13 ’24, was worth 179,934. In this transaction 10% Owner of this company sold 2,998,908 shares at a rate of $0.06, taking the stock ownership to the 13,005,169 shares. Before that another transaction happened on Dec 12 ’24, when Company’s 10% Owner sold 1,614,541 for $0.07, making the entire transaction worth $113,018. This insider now owns 16,004,077 shares in total.
CERo Therapeutics Holdings Inc (CERO) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 51.33% per share during the next fiscal year.
CERo Therapeutics Holdings Inc (NASDAQ: CERO) Trading Performance Indicators
Check out the current performance indicators for CERo Therapeutics Holdings Inc (CERO). In the past quarter, the stock posted a quick ratio of 0.73.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -498.80, a number that is poised to hit -70.20 in the next quarter and is forecasted to reach -56.90 in one year’s time.
Technical Analysis of CERo Therapeutics Holdings Inc (CERO)
Analysing the last 5-days average volume posted by the [CERo Therapeutics Holdings Inc, CERO], we can find that recorded value of 12.63 million was better than the volume posted last year of 0.61 million. As of the previous 9 days, the stock’s Stochastic %D was 16.78%.
During the past 100 days, CERo Therapeutics Holdings Inc’s (CERO) raw stochastic average was set at 2.55%, which indicates a significant decrease from 7.15% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 527.34% in the past 14 days, which was higher than the 233.31% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $12.37, while its 200-day Moving Average is $108.44. Now, the first resistance to watch is $11.49. This is followed by the second major resistance level at $14.83. The third major resistance level sits at $16.51. If the price goes on to break the first support level at $6.47, it is likely to go to the next support level at $4.79. Should the price break the second support level, the third support level stands at $1.45.
CERo Therapeutics Holdings Inc (NASDAQ: CERO) Key Stats
There are currently 386K shares outstanding in the company with a market cap of 4.21 million. Presently, the company’s annual sales total 0 K according to its annual income of -8,300 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -5,110 K.